MEK INHIBITOR TRAMETINIB IN HIGH GRADE OVARIAN CANCER PROLIFERATION

被引：0
|
作者：
Chesnokov, Mikhail [1 ]
Jamroze, Anmbreen [1 ]
Ha, Wootae [1 ]
Chefetz, Ilana [1 ]
机构：
[1] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA
来源：
CLINICAL CANCER RESEARCH | 2019年 / 25卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
GMM-019
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [21] Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib
    Kim, Junyeol
    Lee, Tae Seung
    Lee, Myeong Hwan
    Cho, In Rae
    Ryu, Ji Kon
    Kim, Yong-Tae
    Lee, Sang Hyub
    Paik, Woo Hyun
    CANCERS, 2024, 16 (05)
  • [22] Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib
    Romane Florent
    Louis-Bastien Weiswald
    Bernard Lambert
    Emilie Brotin
    Edwige Abeilard
    Marie-Hélène Louis
    Guillaume Babin
    Laurent Poulain
    Monique N’Diaye
    Cell Death & Disease, 11
  • [23] MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis
    Musacchio, Lucia
    Valsecchi, Anna Amela
    Salutari, Vanda
    Valabrega, Giorgio
    Camarda, Floriana
    Tuninetti, Valentina
    Giannone, Gaia
    Bartoletti, Michele
    Marchetti, Claudia
    Pignata, Sandro
    Fagotti, Anna
    Scambia, Giovanni
    Di Maio, Massimo
    Lorusso, Domenica
    CANCER TREATMENT REVIEWS, 2022, 110
  • [24] Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor
    Lazow, Margot A.
    Lawson, Sarah A.
    Salloum, Ralph
    Hummel, Trent R.
    Smiley, Natasha Pillay
    DeWire-Schottmiller, Mariko D.
    Fouladi, Maryam
    de Blank, Peter
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (04) : E550 - E553
  • [25] SYNERGISTIC TREATMENT FOR PEDIATRIC LOW GRADE GLIOMA WITH THE DUAL MTORC1/2 INHIBITOR TAK-228 AND MEK INHIBITOR TRAMETINIB
    Arnold, Antje
    Rodriguez, Fausto
    Eberhart, Charles
    Raabe, Eric
    NEURO-ONCOLOGY, 2017, 19 : 35 - 36
  • [26] Combinatory treatment for pediatric low grade glioma with the dual mTORC1/2 inhibitor TAK228 and MEK inhibitor Trametinib
    Arnold, Antje
    Rodriguez, Fausto
    Eberhart, Charles George
    Raabe, Eric Hutton
    CANCER RESEARCH, 2017, 77
  • [27] Treatment of QNAQ mutated, advanced Uveal Melanoma with the MEK Inhibitor Trametinib
    Sakar, H.
    Scholler, A.
    Gaiser, M. R.
    Utikal, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 49 - 49
  • [28] TREATMENT OF REFRACTORY ROSAI-DORFMAN DISEASE WITH THE MEK INHIBITOR TRAMETINIB
    Carroll, Clinton
    Greer, Amy
    Evans, Misty
    Bruce, Kathryn
    Edens, Cheryl
    Pierre, Ketsia
    Domm, Jennifer
    Frangoul, Haydar
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S177 - S178
  • [29] NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells
    Furuhashi, Satoshi
    Sugita, Hiroki
    Takamori, Hiroshi
    Horino, Kei
    Nakahara, Osamu
    Okabe, Hirohisa
    Miyake, Keisuke
    Tanaka, Hiroshi
    Beppu, Toru
    Baba, Hideo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (03) : 807 - 815
  • [30] Activity of the MEK inhibitor Binimetinib (MEK162) in combination with paclitaxel in patient-derived xenograft models of high-grade serous ovarian carcinoma
    Winski, Shannon L.
    Bouhana, Karyn
    Rhodes, Susan
    Cable, LouAnn
    Anderson, Deborah
    Williams, Lance
    Tunquest, Brian
    Logan, Tiffany
    Vigers, Guy
    Lee, Patrice
    CANCER RESEARCH, 2015, 75
12345